(16 Aug 2021) Growing global demand for cargo services has doubled the size of China Airlines’ cold chain logistics business.
The number of temperature-controlled containers transported by China Airlines between January and July 2021 grew by 220% year-on-year, and the outlook continues to be positive.
China Airlines was also the first carrier in Taiwan to obtain CEIV Pharma certification for pharmaceutical cold chain logistics.
The airline has been used to transport Moderna and AstraZeneca vaccines from Luxembourg, Amsterdam (Netherlands), Bangkok (Thailand), Memphis (USA) and other locations back to Taiwan.
CAL’s extensive network was also used to transship vaccines purchased by other countries to their final destinations via Taiwan, with a number of vaccine shipments already transshipped to other Asian countries.
According to IATA statistics, China Airlines maintained its lead in international air cargo, with cargo volumes continuing to grow. In 2020, China Airlines climbed into the world’s top 5 carriers by air cargo volume, carrying 1.55 million tonnes of cargo, an increase of 12.8% compared to that of 2019.
In terms of Freight Tonne-Kilometers (FTK), China Airlines carried 6,317 million FTK in 2020, up 18.4% from the previous year. It was ranked 10th in the world and saw the most growth in cargo volume out of all the top 10 carriers.
A fleet of 21 freighter aircraft including 3 newly introduced 777 freighters and 18 existing 747 freighters helped China Airlines strengthen its competitive edge in air cargo industry.
In the second half of 2021, China Airlines will continue to focus on its cargo business. The 21 freighters along with the belly holds of passenger aircraft will be used to carry mail and packages, while particular emphasis will also be placed on the demand for express freight, additional freighter services, and charter requirements.